MARKET

NXTC

NXTC

NextCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

44.53
-0.07
-0.16%
Opening 10:17 01/28 EST
OPEN
44.94
PREV CLOSE
44.60
HIGH
45.63
LOW
44.50
VOLUME
37.47K
TURNOVER
--
52 WEEK HIGH
109.00
52 WEEK LOW
13.86
MARKET CAP
976.78M
P/E (TTM)
-33.5746
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NXTC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NXTC News

  • Comcast -1.2% as UBS sees investments weighing growth
  • Seeking Alpha - Article.4d ago
  • Here are the biggest analyst calls of the day: Alphabet, Apple, PayPal, Intel & more
  • CNBC.com.4d ago
  • ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q4 2019
  • Seeking Alpha - Article.4d ago
  • Wall Street Breakfast: Last Day In Davos
  • Seeking Alpha - Article.4d ago

More

Industry

Pharmaceuticals
+0.46%
Pharmaceuticals & Medical Research
+0.63%

Hot Stocks

Name
Price
%Change

About NXTC

Nextcure Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases. The Company uses its functional integrated nextcure discovery in immune oncology (FIND-IO) technology to functional screening approaches for the identification of targets from multiple therapeutic areas, including autoimmunity and neurology, enabling immunomedicine to treat unmet medical needs. Its product pipelines include NC318, a immunotherapeutic against a immunomodulatory target found on a restricted set of myeloid and tumor cells, and NC410, a immunomedicine designed to block an immune regulator expressed on T cells and suppressive antigen-presenting cell populations, including dendritic cell subpopulations.
More

Webull offers NextCure Inc (NXTC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.